NCT04504032 A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) Status TERMINATED Phase PHASE2
NCT04503434 Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support Status COMPLETED Phase N/A
NCT04502472 Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma Status TERMINATED Phase PHASE2/PHASE3
NCT04502069 Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen Status WITHDRAWN Phase PHASE1/PHASE2
NCT04501952 Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting Status TERMINATED Phase PHASE3
NCT04501783 Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 Status COMPLETED Phase PHASE3
NCT04500132 To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia Status COMPLETED Phase PHASE2
NCT04499677 FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals Status COMPLETED Phase PHASE2
NCT04498325 Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19) Status WITHDRAWN Phase PHASE1
NCT04498299 Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness Status UNKNOWN Phase N/A
NCT04498273 COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Status TERMINATED Phase PHASE3
NCT04497987 A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff Status COMPLETED Phase PHASE3
NCT04497948 Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 Status TERMINATED Phase PHASE1
NCT04497324 PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19 Status COMPLETED Phase PHASE2
NCT04497298 Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine Status COMPLETED Phase PHASE1
NCT04495101 Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 Status COMPLETED Phase PHASE2
NCT04494984 A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. Status COMPLETED Phase PHASE2/PHASE3